Progression to Anti-TNF Treatment in Very Early Onset Inflammatory Bowel Disease Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Pediatric Gastroenterology and Nutrition"
DOI: 10.1097/mpg.0000000000003551
Abstract: Objectives: Limited data are currently available regarding anti-tumor necrosis factor (TNF) use and outcomes in very early onset inflammatory bowel disease (VEOIBD) patients. We aimed to assess the long-term outcomes and time to progression to… read more here.
Keywords: progression anti; anti tnf; disease; treatment ... See more keywords